We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VNDA market cap is 279.3M. The company's latest EPS is USD 0.0430 and P/E is 111.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 38.82M | 45.27M | 47.46M | 50.47M | 47.65M |
| Operating Income | -6M | -7.09M | -9.24M | -10.15M | -11M |
| Net Income | 137k | -2.4M | -4.15M | -4.52M | -5.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 227.19M | 248.17M | 268.68M | 254.38M | 192.64M |
| Operating Income | 22.81M | 27.24M | 42.17M | 6.33M | -13.95M |
| Net Income | 115.55M | 23.34M | 33.15M | 6.28M | 2.51M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 641.61M | 648.44M | 652.68M | 651.37M | 645.12M |
| Total Liabilities | 98.51M | 103.53M | 108.69M | 108.86M | 103.89M |
| Total Equity | 543.1M | 544.91M | 544M | 542.52M | 541.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 483.75M | 533.46M | 593.79M | 634.25M | 648.44M |
| Total Liabilities | 72.8M | 80.19M | 88.86M | 107.05M | 103.53M |
| Total Equity | 410.95M | 453.27M | 504.93M | 527.2M | 544.91M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 16.53M | 12.8M | 7.57M | 641k | -13.94M |
| Investing | 31.73M | -12.06M | -18.22M | -33.48M | -21.42M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 45.95M | 51.78M | 64.21M | 31.98M | 12.8M |
| Investing | -68.31M | -41.5M | -76.7M | 49.93M | -12.06M |
| Financing | 6.26M | 5.63M | 3.55M | 734k | N/A |
| Market Cap | 279.3M |
| Price to Earnings Ratio | 111.40 |
| Price to Sales Ratio | 1.45 |
| Price to Cash Ratio | 2.06 |
| Price to Book Ratio | 0.51 |
| Dividend Yield | - |
| Shares Outstanding | 58.31M |
| Average Volume (1 week) | 421.5k |
| Average Volume (1 Month) | 675.97k |
| 52 Week Change | 14.05% |
| 52 Week High | 6.75 |
| 52 Week Low | 3.46 |
| Spread (Intraday) | 0.11 (2.26%) |
| Company Name | Vanda Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vandapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
